17-47335305-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000331493.7(EFCAB13):āc.140A>Cā(p.Glu47Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000995 in 1,607,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000331493.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFCAB13 | NM_152347.5 | c.140A>C | p.Glu47Ala | missense_variant | 5/25 | ENST00000331493.7 | NP_689560.3 | |
EFCAB13 | NM_001195192.2 | c.140A>C | p.Glu47Ala | missense_variant | 5/22 | NP_001182121.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB13 | ENST00000331493.7 | c.140A>C | p.Glu47Ala | missense_variant | 5/25 | 1 | NM_152347.5 | ENSP00000332111 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000823 AC: 2AN: 243156Hom.: 0 AF XY: 0.00000762 AC XY: 1AN XY: 131308
GnomAD4 exome AF: 0.00000824 AC: 12AN: 1455574Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 723682
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152348Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.140A>C (p.E47A) alteration is located in exon 5 (coding exon 2) of the EFCAB13 gene. This alteration results from a A to C substitution at nucleotide position 140, causing the glutamic acid (E) at amino acid position 47 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at